MDMA/Synthesis: Difference between revisions

>Kenan
m Use proper synth for MDMA by shulgin (previous was MDPEA by mistake)
>Kenan
m Seems like the OCR doesn't like shulgins' D
Line 38: Line 38:
=== Synthesis ===
=== Synthesis ===


* From safrole (with aqueous HBr) to 5-(2-bromopropyl)benzo-1,3-dioxole; (with methyl­ amine in EtOH) to MOMA (Merck, 1912; Bineicki and Krajewski, 1960).
* From safrole (with aqueous HBr) to 5-(2-bromopropyl)benzo-1,3-dioxole; (with methyl­ amine in EtOH) to MDMA (Merck, 1912; Bineicki and Krajewski, 1960).
* From 3,4-methylenedioxyphenylacetone (aka: piperonylacetone; with methylamine, sodium cyanoborohydride) to MOMA (Braun et al., 1980).
* From 3,4-methylenedioxyphenylacetone (aka: piperonylacetone; with methylamine, sodium cyanoborohydride) to MDMA (Braun et al., 1980).
* From MOA (with formic acid or ethyl formate) to ''N''-formyl-3,4-methylenedioxy­ amphetamine; (with LAH) to MOMA (Shulgin and Shulgin, 1991)
* From MDA (with formic acid or ethyl formate) to ''N''-formyl-3,4-methylenedioxy­ amphetamine; (with LAH) to MDMA (Shulgin and Shulgin, 1991)
* From isosafrole (with formic acid, H<sub>2</sub>0<sub>2</sub>) to 3,4-methylenedioxyphenylacetone; (with Al, HgCl<sub>2</sub>, CH<sub>3</sub>NH<sub>2</sub>) to MOMA (Shulgin and Shulgin, 1991).
* From isosafrole (with formic acid, H<sub>2</sub>0<sub>2</sub>) to 3,4-methylenedioxyphenylacetone; (with Al, HgCl<sub>2</sub>, CH<sub>3</sub>NH<sub>2</sub>) to MDMA (Shulgin and Shulgin, 1991).
* (For the optical isomers) from piperonylacetone (with ''R''-(-)- (or ''S''-(+)-) &alpha;-methylbenzyl­ amine, Raney Ni) to ''R'',''R''- (or ''S'',''S'') ''N''-&alpha;-methylbenzyl-MOA; (with Pd, H<sub>2</sub>) to ''R''-(-)- (or ''S''-(+)-) MOA; (with methyl formate) to ''R''-(+)- (or ''S''-(-) ''N''-formamido-MOA; (with LAH) to ''R''-(-)­ (or ''S''-(+)-) MOMA (Anderson et al., 1978a).
* (For the optical isomers) from piperonylacetone (with ''R''-(-)- (or ''S''-(+)-) &alpha;-methylbenzyl­ amine, Raney Ni) to ''R'',''R''- (or ''S'',''S'') ''N''-&alpha;-methylbenzyl-MOA; (with Pd, H<sub>2</sub>) to ''R''-(-)- (or ''S''-(+)-) MDA; (with methyl formate) to ''R''-(+)- (or ''S''-(-) ''N''-formamido-MDA; (with LAH) to ''R''-(-)­ (or ''S''-(+)-) MDMA (Anderson et al., 1978a).


== M. Swist, J. Wilamowski, A. Parczewski ==
== M. Swist, J. Wilamowski, A. Parczewski ==